Gambaran Faktor Risiko Kanker Endometrium di RSUP Dr. Hasan Sadikin pada Tahun 2020 – 2022

Febia Erfiandi, Shalma Alaika Aurel Balqis, Siti Salima, Kemala Isnainiasih Mantilidewi, Andi Kurniadi, Viko Duvadilan Wibowo


Abstract


Tujuan: Mengetahui faktor risiko pasien kanker endometrium di RSUP Dr. Hasan Sadikin pada Tahun 2020 – 2022.
Metode: Penelitian metode deskriptif dengan menggunakan data sekunder. Kriteria inklusi yaitu pasien dengan diagnosis utama kanker endometrium.
Hasil: Mayoritas pasien kanker endometrium berusia 50 – 59 tahun (34,8%), multipara (40,9%), Indeks Masa Tubuh ≥25 kg/m2 (33,2%), usia menarche ≥12 tahun (68,8%), tidak memiliki riwayat infertilitas (49,0%), belum menopause (36,4%), tidak memiliki riwayat terapi hormon (74,1%), pasien tidak memiliki riwayat kanker/lynsch syndrome (71,7%), tidak memiliki riwayat keluarga dengan lynch syndrome (75,7%), tidak menggunakan kontrasepsi (42,5%), dan tidak memiliki riwayat hipertensi (72,9%).
Kesimpulan: Pasien kanker endometrium di RSUP Dr. Hasan Sadikin Bandung periode tahun 2020 – 2022 ditemukan paling banyak pada rentang usia 50 – 59 tahun, status paritas yaitu multi para (≥2 kelahiran hidup), indeks massa tubuh ≥25 (obesitas), belum menopause, usia menarche ≥12 tahun, tidak memiliki riwayat terapi hormon, tidak terdapat riwayat infertilitas, pasien tanpa riwayat kanker, tidak memiliki riwayat keluarga dengan kanker, tidak menggunakan kontrasepsi, dan tidak memiliki riwayat hipertensi.

Overview of Endometrial Cancer Risk Factors at RSUP Dr. Hasan Sadikin in 2020 - 2022

Abstract
Objective: Indentifying the risk factor of endometrial cancer patients at RSUP Dr. Hasan Sadikin in 2020 - 2022.
Method: This research used descriptive method by collecting secondary data. The inclusion criteria was patients with primary diagnosis of endometrial cancer
Results: In this research, the majority of endometrial cancer patients were aged 50 - 59 years (34,8%), multiparous (40,9%), with body mass index ≥25 kg/m² (33,2%), menarche age of ≥12 years (68,8%), no history of infertility (49,0%), not menopausal yet (36,4%), no history of hormone therapy (74,1%), no patient history of cancer/Lynch syndrome (71,7%), no family history of lynch syndrome (75,7%), no history of contraceptive use (42,55), and no history of hypertension (72,9%).
Conclusion: In 2020 - 2022, endometrial cancer patient in Dr. Hasan Sadikin Central General Hospital Bandung were mostly foung in the aged range 50 - 59 years, multiparous, obesity, not menopausal yet, menarche age of ≥12 years, no history of hormone therapy, no patient and family history of cancer, no history of contraceptive use and hypertension.

Key words: Endometrial cancer, risk factor, descriptive study


Keywords


Kanker endometrium, faktor risiko, penelitian deskriptif

Full Text:

PDF

References


Berek JS. Berek & Novak’s Gynecology. 16th ed. 2020. 2359–2444 p.

World Cancer Research Fund International. Endometrial Cancer Statistics. 2022. Available from: https://www.wcrf.org/cancer-trends/endometrial-cancer-statistics/

American Cancer Society. Key Statistics for Endometrial Cancer. 2023. Available from: https://www.cancer.org/cancer/endometrial-cancer/about/key-statistics.html

Varughese J, Richman S. Cancer care inequity for women in resource-poor countries. Rev Obstet Gynecol. 2010;3(3):122–32.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May 4;71(3):209–49.

WHO. Indonesia. 2020.

Vietri MT, D’Elia G, Caliendo G, Casamassimi A, Federico A, Passariello L, et al. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer. Med Oncol. 2021 Jan 23;38(2):13.

American Cancer Society. Endometrial Cancer Risk Factors. 2019. Available from: https://www.cancer.org/cancer/types/endometrial-cancer/causes-risks-prevention/risk-factors.html

Michels KA, Pfeiffer RM, Brinton LA, Trabert B. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. JAMA Oncol. 2018 Apr 1;4(4):516.

Wu Y, Sun W, Liu H, Zhang D. Age at Menopause and Risk of Developing Endometrial Cancer: A Meta-Analysis. Biomed Res Int. 2019 May 29;2019:1–13.

Hag-Yahia N, Gemer O, Eitan R, Raban O, Vaknin Z, Levy T, et al. Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study. Acta Obstet Gynecol Scand. 2021 Mar;100(3):444–52.

WHO. Corpus uteri Source: Globocan 2020. 2020. Available from: https://gco.iarc.fr/today

Sofyan N, Sudiana IK, Askandar B. Profile of Endometrial Cancer Patients in the Third Referral Hospital in Surabaya based on Known Risk Factors. Biomolecular and Health Science Journal. 2020 Oct 30;3(2):66.

Mahrani D, Attamimi A, Kusumanto A. Hubungan antara Faktor Klinikohistopatologi dan Kualitas Hidup Pasien Kanker Endometrium Pasca Operasi di RSUP Dr.Sardjito Yogyakarta Menggunakan Modul Kuesioner EORTC QLQ-C30 dan EN 24. Jurnal Kesehatan Reproduksi. 2021 Apr 13;8(1):23.

Chen Q, Tong M, Guo F, Lau S, Zhao M. Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer. J Cancer. 2015;6(11):1087–92.

Onstad MA, Schmandt RE, Lu KH. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J Clin Oncol. 2016 Dec 10;34(35):4225–30.

Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de González A, et al. Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. Cancer Res. 2021 Apr 15;81(8):2246–55.

Lacroix AE, Gondal H, Shumway KR, Langaker MD. Physiology, Menarche. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470216/

Evitasari D, Euis Citra Intan Suteja N. Bunda Edu-Midwifery Journal (Bemj) Hubungan Pengetahuan Dengan Tingkat Kecemasan Remaja Putri Dalam Menghadapi Haid Pertama (Menarche) Pada Siswi Kelas Vii Di Mts Negeri 7 Sumedang Tahun 2022. Vol. 5. 2022.

Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, et al. Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). Br J Cancer. 2015 Mar 3;112(5):925–33.

Cetin I, Cozzi V, Antonazzo P. Infertility as a Cancer Risk Factor - A Review. Placenta. 2008 Oct;29(SUPPL.2):169–77.

Tempfer CB, Hilal Z, Kern P, Juhasz-Boess I, Rezniczek GA. Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review. Cancers (Basel). 2020 Aug 6;12(8).

Mahdy H, Casey MJ, Crotzer D. Endometrial Cancer. 2023.

Win AK, Reece JC, Ryan S. Family history and risk of endometrial cancer: a systematic review and meta-analysis. Obstetrics and gynecology. 2015 Jan;125(1):89–98.

Bhattacharya P, McHugh TW. Lynch Syndrome. 2023.

Iversen L, Fielding S, Lidegaard Ø, Hannaford PC. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women. Contraception. 2020 Sep;102(3):152–8.

Britton LE, Alspaugh A, Greene MZ, McLemore MR. CE: An Evidence-Based Update on Contraception. Am J Nurs. 2020 Feb;120(2):22–33.

Pradnya P, Dewi P, Nyoman I, Budiana G. Profil Pasien Kanker Endometrium Di Rsup Sanglah Denpasar Periode Agustus 2012-Juli 2014. Vol. 6, JURNAL MEDIKA. 2017. Available from: http://ojs.unud.ac.id/index.php/eum

Aune D, Sen A, Vatten LJ. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep. 2017 Apr 7;7(1):44808.




DOI: http://dx.doi.org/10.24198/obgynia/v6.n3.578

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


     
     

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat